CAH 📈 Cardinal Health - Overview

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US14149Y1082

CAH: Pharmaceuticals, Medical Supplies, Surgical Products, Gloves, Needles, Syringes

Cardinal Health Inc. is a leading healthcare services and products company that operates globally, with a presence in the United States, Canada, Europe, Asia, and other international markets. The company provides tailored solutions to a wide range of healthcare providers, including hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients receiving care in their homes.

Cardinal Health's business is divided into two main segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company distributes a vast array of products, including branded and generic pharmaceuticals, specialty pharmaceuticals, over-the-counter healthcare products, and medical supplies. Additionally, it offers specialized services to pharmaceutical manufacturers and healthcare providers, such as pharmacy management services to hospitals and repackaging of generic pharmaceuticals and over-the-counter healthcare products.

In the medical products space, Cardinal Health designs, manufactures, sources, and distributes a broad portfolio of Cardinal Health branded products, including exam and surgical gloves, needles, syringe, and sharps disposals, compression solutions, incontinence products, nutritional delivery systems, wound care products, and more. The company also distributes a range of national brand products, including medical, surgical, and laboratory products, and provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers.

Furthermore, Cardinal Health assembles and sells sterile and non-sterile procedure kits, and manufactures, prepares, delivers, and distributes radiopharmaceuticals and related treatments. The company also leverages its integrated technology solutions to optimize direct shipments and streamline logistics for its customers.

Founded in 1979, Cardinal Health is headquartered in Dublin, Ohio, and has established itself as a trusted partner to healthcare providers around the world. With a strong commitment to improving patient care and outcomes, the company continues to innovate and expand its offerings to meet the evolving needs of the healthcare industry.

Additional Sources for CAH Stock

CAH Stock Overview

Market Cap in USD 29,487m
Sector Healthcare
Industry Medical Distribution
GiC Industry Health Care Providers & Services
TER 0.00%
IPO / Inception 1987-12-31

CAH Stock Ratings

Growth 5y 89.0%
Fundamental 53.6%
Dividend 51.8%
Rel. Performance Sector 0.31
Analysts 3.35/5
Fair Price Momentum 133.90 USD
Fair Price DCF 113.42 USD

CAH Dividends

Dividend Yield 12m 1.63%
Yield on Cost 5y 4.27%
Annual Growth 5y 0.80%
Payout Consistency 95.36%

CAH Growth Ratios

Growth Correlation 3m 66.3%
Growth Correlation 12m 42.4%
Growth Correlation 5y 92.2%
CAGR 5y 21.19%
CAGR/Mean DD 5y 2.61
Sharpe Ratio 12m 0.63
Alpha -8.28
Beta 0.71
Volatility 21.91%
Current Volume 1451k
Average Volume 20d 2335.5k
What is the price of CAH stocks?
As of December 04, 2024, the stock is trading at USD 123.27 with a total of 1,451,030 shares traded.
Over the past week, the price has changed by +0.68%, over one month by +10.16%, over three months by +8.00% and over the past year by +16.94%.
Is Cardinal Health a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Cardinal Health (NYSE:CAH) is currently (December 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 53.64 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CAH as of December 2024 is 133.90. This means that CAH is currently overvalued and has a potential downside of 8.62%.
Is CAH a buy, sell or hold?
Cardinal Health has received a consensus analysts rating of 3.35. Therefor, it is recommend to hold CAH.
  • Strong Buy: 4
  • Buy: 1
  • Hold: 10
  • Sell: 1
  • Strong Sell: 1
What are the forecast for CAH stock price target?
According to ValueRays Forecast Model, CAH Cardinal Health will be worth about 146.3 in December 2025. The stock is currently trading at 123.27. This means that the stock has a potential upside of +18.65%.
Issuer Forecast Upside
Wallstreet Target Price 123.8 0.4%
Analysts Target Price 98.6 -20%
ValueRay Target Price 146.3 18.7%